Medical/Pharmaceuticals
Metabolon's Metabolomics Services Now Cited in More Than 4,000 Peer-Reviewed Publications
Metabolon's best-in-class metabolomics leadership accelerates as metabolomics
becomes a standard inclusion in global multiomics studies
MORRISVILLE, N.C., Oct. 7, 2025 /PRNewswire/ -- Metabolon
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized...
Pantai Hospital Kuala Lumpur at Kuala Lumpur Standard Chartered Marathon 2025
From preventive screenings to Medic-On-The-Run, Pantai Hospital Kuala Lumpur brings healthcare beyond the hospital for Generation after Generation. KUALA LUMPUR, Malaysia, Oct. 7, 2025 /PRNewswire/ -- Health, like running, is a journey, not a destination. AsMalaysia's runners pushed their limits ...
Kadisco General Hospital and MindHYVE.ai™ Sign Strategic MoU to Transform Healthcare in Ethiopia with Agentic AI
ADDIS ABABA, Ethiopia, Oct. 7, 2025 /PRNewswire/ -- Kadisco General Hospital (KGH), one of Ethiopia's leading private healthcare institutions, and MindHYVE.ai™, a U.S.-based pioneer in agentic artificial intelligence (AI), have signed a Memorandum of Understanding (MoU) to launch an ambitious co...
Terumo Blood and Cell Technologies Honored with Corporate Excellence Award at the Asia Pacific Enterprise Awards 2025 Regional Edition
SINGAPORE, Oct. 7, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) has been recognized with the Corporate Excellence Award at the Asia Pacific Enterprise Awards (APEA) 2025 Regional Editionorganized by Enterprise Asia, a testament to its unwavering commitment to innovation, ...
Japanese Innovation Comes to Thailand: Revolutionary Myopia Management Device Kubota Glass Debuts at ASEAN International Optics Fair Bangkok 2025
TOKYO, Oct. 7, 2025 /PRNewswire/ -- Leading Japanese pharmaceutical company
Kubota Pharmaceutical Holdings Co., Ltd. will introduceThailand to its
groundbreaking myopia management device,Kubota Glass, at Bangkok.
Revolutionary Myopia Management Technology Expands Across Asia -- Kubota Glass Makes Global Debut at ASEAN International Optics Fair Bangkok 2025
TOKYO, Oct. 7, 2025 /PRNewswire/ -- Kubota Pharmaceutical Holdings Co., Ltd. (TSE: 4596) today announced that its groundbreaking myopia management device, Kubota Glass, will make its international debut at ASEAN International Optics Fair Bangkok 2025, taking place inBangkok, Thailand, from Octo...
Colebrook Bosson Saunders Celebrates 35 Years of Human-Centric Design
HONG KONG, Oct. 7, 2025 /PRNewswire/ -- Colebrook Bosson Saunders (CBS)
UEG Week 2025: Microplastics found to change gut microbiome in first human-sample study
BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week 2025 shows that microplastics – plastic particles smaller than 5mm commonly found in the environment – can alter the human gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer...
NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month
The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for more than a dozen cancer types, along with hereditary risk assessment, featuring seamless integration with additional resources. PLYMOU...
Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets
New CSO & GM role underscores Halia's commitment to resilience-based therapeutic development and advances collaboration with the Department of Health –Abu Dhabi LEHI, Utah, Oct. 6, 2025 /PRNewswire/ -- Halia Therapeutics (The Genetic Resilience Company), a clinical-stage biopharmaceutical compa...
Olympus and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the Olympus EndoTherapy Portfolio
CENTER VALLEY, Pa., and HAMBURG, Germany, Oct. 6, 2025 /PRNewswire/ -- Olympus Corporation, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, has entered into an international distribution agreement with the medical products business of U.S.-basedW....
FDA Lifts Clinical Hold on NUZ-001
Highlights: * U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS * Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 * IND supported by robust preclinical safety data and comprehensive manufacturing and ...
Hong Kong Tech Startup Advances AI Lung Cancer Screening Project, Supporting the Fight Against City's Top Cancer Killer
HONG KONG, Oct. 4, 2025 /PRNewswire/ -- Caretia, a local tech startup based at Hong Kong Science Park, today announced that its AI-powered lung cancer screening platform has achieved initial milestones and entered a new phase of development. This progress aligns closely with the direction set out...
Positioning Da Nang as Southeast Asia's Leading Medical Tourism Hub at the Da Nang Global Business Summit 2025
DA NANG, Vietnam, Oct. 3, 2025 /PRNewswire/ -- Da Nang is set to host the Da Nang Global Business Summit 2025 under the theme "Unlocking the Future of Medical & Wellness Tourism: Innovation – Creativity – Global Connectivity". The two-day event will take place onNovember 11–12, 2025, at Fusion Re...
Mediso installs true theranostic TheraMAX SPECT/CT at Heidelberg University Hospital
HEIDELBERG, Germany, Oct. 3, 2025 /PRNewswire/ -- Mediso completes the
installation of an AnyScan® TRIO-TheraMAX SPECT/CT at the Department of Nuclear
Medicine at Heidelberg University Hospital.
Nutromics unveils world-first real-time in vivo multiplexing data at IATDMCT
MELBOURNE, Australia, Oct. 3, 2025 /PRNewswire/ -- Diagnostics company Nutromics has presented the world's first real-time, continuous data on two critical antibiotics - vancomycin and tobramycin - measured simultaneously on the same device in animal models. The breakthrough was unveiled at the ...
MedHub-AI Announces National Reimbursement Approval in Japan for AutocathFFR™
TEL AVIV, Israel, Oct. 3, 2025 /PRNewswire/ -- MedHub-AI
Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States
* The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as the reference product ACTEMRA® (tocilizumab) * AVTOZMA is Celltrion's fifth immunology biologic and seventh biosimilar approved by the FDA * This launch stre...
AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing
* Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional medicine with state-of-the-art technologies. * Patented Flagship NB-A002 is a First-in-class DNA...
Week's Top Stories
Most Reposted
Tetra Pak Opens Product Development Centre in Thailand, Unlocking A World of Possibilities for Food and Beverage Innovators Across Asia Pacific
[Picked up by 316 media titles]
2026-03-27 11:15Visa Working Capital Index: Asia Pacific CFOs Call for Flexible, Digital Finance Solutions
[Picked up by 310 media titles]
2026-03-24 14:00Indonesia's P2P Lending Grows 25%, JULO Strengthens Credit Quality
[Picked up by 300 media titles]
2026-03-26 18:18ART CENTRAL COMMENCES DISCOVERY-LED ELEVENTH EDITION
[Picked up by 277 media titles]
2026-03-25 16:51Noah Reports Q4 and Full Year 2025 Earnings: Structural Transformation Driving Significant Improvement in Profitability as AI Integration Drives Operational Efficiency
[Picked up by 269 media titles]
2026-03-25 21:58